AJP - GI AJP citation statistics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 296: G1191-G1199, 2009. First published April 9, 2009; doi:10.1152/ajpgi.90717.2008
0193-1857/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/6/G1191    most recent
90717.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Harris, E. N.
Right arrow Articles by Weigel, P. H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harris, E. N.
Right arrow Articles by Weigel, P. H.

LIVER AND BILIARY TRACT

Rat and human HARE/stabilin-2 are clearance receptors for high- and low-molecular-weight heparins

Edward N. Harris, Bruce A. Baggenstoss, and Paul H. Weigel

Department of Biochemistry and Molecular Biology and The Oklahoma Center for Medical Glycobiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Submitted 22 December 2008 ; accepted in final form 7 April 2009

The human hyaluronic acid (HA) receptor for endocytosis (HARE/stabilin-2) is the primary clearance receptor for systemic HA, chondroitin sulfates, and heparin, but not for heparan sulfate or keratan sulfate (Harris EN, Weigel JA, Weigel PH. J Biol Chem 283: 17341–17350, 2008). HARE is expressed in the sinusoidal endothelial cells (SECs) of liver and lymph nodes where it acts as a scavenger for uptake and degradation of glycosaminoglycans, both as free chains and proteoglycan fragments. Unfractionated heparin (UFH; ~14 kDa) and low-molecular-weight heparin (LMWH; ~4 kDa) are commonly used in treatments for thrombosis and cancer and in surgical and dialysis procedures. The reported half-lives of UFH and LMWH in the blood are ~1 h and 2–6 h, respectively. In this study, we demonstrate that anti-HARE antibodies specifically block the uptake of LMWH and UFH by isolated rat liver SECs and by human 293 cells expressing recombinant human HARE (hHARE). hHARE has a significant affinity (Kd = 10 µM) for LMWH, and higher affinity (Kd = 0.06 µM) for the larger UFH. Rat liver SECs or cells expressing the recombinant 190-kDa HARE isoform internalized both UFH and LMWH, and both heparins cross-compete with each other, suggesting that they share the same binding sites. These cellular results were confirmed in ELISA-like assays using purified soluble 190-hHARE ectodomain. We conclude that both UFH and LMWH are cleared by HARE/Stab2 and that the differences in the affinities of HARE binding to LMWH and UFH likely explain the longer in vivo circulating half-life of LMWH compared with UFH.

Lovenox (enoxaparin); endocytosis; scavenger receptor; biotinylated heparin; coated pit mediated; liver sinusoidal endothelial cells



Address for reprint requests and other correspondence: E. N. Harris, Dept. of Biochemistry and Molecular Biology and The Oklahoma Center for Medical Glycobiology, Univ. of Oklahoma Health Sciences Center, Oklahoma City, OK 73190 (e-mail: edward-harris{at}ouhsc.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.